GradeBio Sheet G‑02  /  Compound register G‑02Rev. A
GradeBio Compound register
Sheet G‑02 of 14
Revision A  ·  31 Aug 2026

Twelve entries,
filed by class.

This page shows the product. It does not sell it. Every entry carries the identifiers you would check us against, and none carries a price, because a price is a term of an account rather than a property of a molecule.

The register is the whole of what is made here, including the entry that was withdrawn in February. It is filed by class and then by entry number, the same order it is filed in the building, and it is reissued as a numbered revision rather than edited in place.

CASThe registry number. The one identifier that cannot be marketed around.
AssayThe floor the material is released to, by HPLC area percent, never a typical figure.
PresentationWhat is in the vial, and at what fill.
StateCurrent, on revision, or withdrawn from the register.
Register  ·  complete

12 entries, 3 classes

Filed by class, then by entry number
Revision A  ·  issued 31 Aug 2026
Thymosin alpha-1, lyophilized cake in a sealed vial.
Thymosin alpha‑102 · Lyophilized
Ipamorelin, lyophilized cake in a sealed vial.
Ipamorelin03 · On revision
BPC-157, lyophilized cake in a sealed vial.
BPC‑15704 · On revision
Glycine, clear solution in a sealed vial.
Glycine06 · Solution
Taurine, clear solution in a sealed vial.
Taurine07 · Solution
L-Carnitine, clear solution in a sealed vial.
L‑Carnitine08 · Solution
Ascorbic acid, clear solution in a sealed vial.
Ascorbic acid09 · Solution
Methylcobalamin, deep red solution in a sealed vial.
Methylcobalamin10 · Solution
Biotin, clear solution in a sealed vial.
Biotin11 · Solution
Pyridoxine hydrochloride, clear solution in a sealed vial.
Pyridoxine hydrochloride12 · Solution
Plates 1 to 12   The twelve entries as filled. Specimen photography. Entries 03 and 04 are held on revision and are shown for the record only.

1.0   Peptides

4 entries · lyophilized
No.CompoundCASFormulaMassAssayPresentationStateSheet
01Sermorelin86168-78-7C149H246N44O42S3357.9≥ 98.0 %Lyophilized, 5 mgCurrentG‑03.01
02Thymosin alpha‑162304-98-7C129H215N33O553108.3≥ 98.0 %Lyophilized, 5 mgCurrentPending
03Ipamorelin170851-70-4C38H49N9O5711.85≥ 98.0 %Lyophilized, 5 mgOn revisionPending
04BPC‑157137525-51-0C62H98N16O221419.5≥ 98.0 %Lyophilized, 5 mgOn revisionPending

2.0   Amino acids and derivatives

4 entries · solution
No.CompoundCASFormulaMassAssayPresentationStateSheet
05Glutathione, reduced70-18-8C10H17N3O6S307.32≥ 99.0 %Solution, 200 mg/mLCurrentG‑03.05
06Glycine56-40-6C2H5NO275.07≥ 99.5 %Solution, 100 mg/mLCurrentPending
07Taurine107-35-7C2H7NO3S125.15≥ 99.0 %Solution, 50 mg/mLCurrentPending
08L‑Carnitine541-15-1C7H15NO3161.20≥ 98.0 %Solution, 200 mg/mLCurrentPending

3.0   Vitamins and cofactors

4 entries · solution
No.CompoundCASFormulaMassAssayPresentationStateSheet
09Ascorbic acid50-81-7C6H8O6176.12≥ 99.0 %Solution, 500 mg/mLCurrentPending
10Methylcobalamin13422-55-4C63H91CoN13O14P1344.4≥ 98.5 %Solution, 1 mg/mLCurrentPending
11Biotin58-85-5C10H16N2O3S244.31≥ 98.5 %Solution, 5 mg/mLCurrentPending
12Pyridoxine hydrochloride58-56-0C8H11NO3·HCl205.64≥ 99.0 %Solution, 100 mg/mLCurrentPending

4.0   Withdrawn

1 entry · retained for traceability
CompoundCASWithdrawnLast lotWhy the row stays
Hydroxocobalamin13422-51-02026‑02‑19L‑23884An account holding an older lot must still be able to reach the paperwork behind it. Deleting the row would delete the history.
Table 4.1   A compound leaves the register the same way it joined it, in writing.
Two entries are held

03 Ipamorelin  ·  04 BPC‑157

Both sit in the group an FDA advisory committee discussed for the 503A bulk substances list in July 2026. That recommendation is advisory. A proposed rule and then a final rule would be required, and neither has issued. Nothing in that group is compoundable today, so both entries are marked on revision and neither is available. No date is stated or implied.

GradeBio

Grade Bio is a brand of Mountain Brands LLC. Entity formation is pending and no registration has been filed. Correspondence to jv@gradebio.com or sw@gradebio.com.

Pre‑launch document Entity pending

The register

The company